🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 13 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/05/2005 | 28,50 | 28,73 | 28,10 | 28,16 | -1,37% | 2,19% | 865.000 |
| 18/05/2005 | 28,00 | 28,83 | 27,90 | 28,55 | +1,96% | 3,32% | 1.114.600 |
| 17/05/2005 | 27,60 | 28,01 | 27,35 | 28,00 | +0,76% | 2,39% | 609.000 |
| 16/05/2005 | 26,89 | 27,80 | 26,66 | 27,79 | +3,16% | 4,22% | 663.600 |
| 13/05/2005 | 27,39 | 27,88 | 26,53 | 26,94 | -1,55% | 4,93% | 782.600 |
| 12/05/2005 | 27,00 | 27,38 | 26,93 | 27,37 | +0,98% | 1,65% | 1.071.800 |
| 11/05/2005 | 27,01 | 27,21 | 26,59 | 27,10 | -0,15% | 2,31% | 687.000 |
| 10/05/2005 | 27,12 | 27,14 | 26,80 | 27,14 | -0,02% | 1,25% | 1.271.600 |
| 09/05/2005 | 26,80 | 27,20 | 26,44 | 27,15 | +1,29% | 2,84% | 710.400 |
| 06/05/2005 | 27,28 | 27,28 | 26,53 | 26,80 | -1,34% | 2,75% | 1.007.200 |
| 05/05/2005 | 26,47 | 27,18 | 26,15 | 27,17 | +3,17% | 3,87% | 1.083.400 |
| 04/05/2005 | 25,55 | 26,67 | 25,55 | 26,33 | +2,79% | 4,36% | 771.200 |
| 03/05/2005 | 24,00 | 25,83 | 23,80 | 25,62 | +3,04% | 8,46% | 2.082.200 |
| 02/05/2005 | 24,23 | 24,87 | 24,12 | 24,86 | +3,60% | 3,12% | 1.108.000 |
| 29/04/2005 | 24,80 | 24,80 | 23,92 | 24,00 | -2,08% | 3,55% | 1.411.800 |
| 28/04/2005 | 25,55 | 25,55 | 24,43 | 24,51 | -3,71% | 4,36% | 969.800 |
| 27/04/2005 | 26,07 | 26,08 | 25,38 | 25,45 | -2,43% | 2,67% | 737.200 |
| 26/04/2005 | 25,88 | 26,46 | 25,70 | 26,09 | +0,50% | 2,94% | 1.250.600 |
| 25/04/2005 | 25,25 | 26,00 | 25,23 | 25,96 | +2,33% | 3,07% | 904.800 |
| 22/04/2005 | 25,57 | 25,69 | 25,13 | 25,37 | -1,25% | 2,21% | 1.312.200 |
| 21/04/2005 | 24,95 | 25,99 | 24,77 | 25,69 | +3,44% | 4,87% | 1.605.400 |
| 20/04/2005 | 24,35 | 24,96 | 24,18 | 24,83 | +2,18% | 3,18% | 1.400.200 |
| 19/04/2005 | 23,51 | 24,51 | 23,51 | 24,30 | +3,36% | 4,23% | 2.408.400 |
| 18/04/2005 | 23,03 | 23,70 | 23,01 | 23,51 | +1,64% | 3,02% | 969.400 |
| 15/04/2005 | 23,25 | 23,25 | 22,43 | 23,13 | -1,30% | 3,53% | 1.139.800 |
| 14/04/2005 | 23,77 | 23,77 | 23,38 | 23,44 | -0,99% | 1,64% | 653.000 |
| 13/04/2005 | 23,92 | 24,12 | 23,50 | 23,67 | -0,32% | 2,59% | 933.000 |
| 12/04/2005 | 22,68 | 23,77 | 22,48 | 23,75 | +3,83% | 5,71% | 1.160.200 |
| 11/04/2005 | 22,68 | 22,87 | 22,44 | 22,87 | +0,51% | 1,92% | 309.800 |
| 08/04/2005 | 23,27 | 23,37 | 22,62 | 22,76 | -1,71% | 3,20% | 556.600 |